FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fresenius Medical Care Holdings Sodium Chloride 0 Recall

Sodium Chloride 0

Fresenius Medical Care Holdings, Inc. · Waltham, MA

Risk level
Class II
Reported by FDA
Mar 25, 2020
Recall ID
D-1064-2020
Check your lot numberHow we source this data

Summary

Fresenius Medical Care Holdings recalled Sodium Chloride 0 starting Mar 5, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1064-2020 on Mar 25, 2020. Reason: CGMP Deviation: Chemical indicators were not positioned properly during sterilization process. Status: Terminated.

Why it was recalled

CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.

Product description

Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451

Lot numbers, UPCs & expiration codes

Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020

Where it was sold

Product was distributed throughout the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1064-2020
Classification
Class II
Status
Terminated
Recall initiated
Mar 5, 2020
FDA report date
Mar 25, 2020
Quantity
32,592 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Medical Care Holdings, Inc.

Original FDA data

Every field from FDA enforcement report D-1064-2020, exactly as published.

Show all FDA fields
City
Waltham
State
MA
Status
Terminated
Country
United States
Event ID
85228
Address
920 Winter St Bld 950
Code information
Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020
Postal code
02451-1521
Report date
Mar 25, 2020
Product type
Drugs
Recall number
D-1064-2020
Classification
Class II
Recalling firm
Fresenius Medical Care Holdings, Inc.
Product quantity
32,592 bags
Termination date
Feb 3, 2023
Reason for recall
CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451
Distribution pattern
Product was distributed throughout the United States.
Recall initiation date
Mar 5, 2020
Initial firm notification
Letter
Center classification date
Mar 26, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1064-2020, published Mar 25, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls